EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which helps manufacturers monitor drug safety in an increasingly complex p
The transformative potential of artificial intelligence (AI) within medical affairs has been widely discussed, yet, realising its real-world commercial value requires a pragmatic approach t
Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelli
While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about
Although it might seem like AI is the newest and hottest innovation in the industry, medical affairs professionals have been using some form of it for decades
Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity.